Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision

Jessica M. Donigan, Mark A. Hyde, David E. Goldgar, Michael L. Hadley, Marianne Bowling, Glen M. Bowen

JAMA Dermatology · 2018 · 32 citations · 14 references

DOIFull text

Open access

Abstract

Neoadjuvant topical imiquimod, 5%, cream prior to conservatively staged excisions for LM allowed for negative histologic margins with a median final margin of 2 mm and a rate of recurrence similar to reported recurrence rates with standard staged excisions by either Mohs surgery or en face permanent sections.

References

14